Old Web
English
Sign In
Acemap
>
Paper
>
90TiP Monalizumab and trastuzumab in metastatic HER2-positive breast cancer: MIMOSA-trial
90TiP Monalizumab and trastuzumab in metastatic HER2-positive breast cancer: MIMOSA-trial
2021
V.C.M. Geurts
Leonie Voorwerk
Karolina Sikorska
M. G. J. van Dongen
Inge Kemper
I. A. M. Mandjes
John B. A. G. Haanen
Gabe S. Sonke
Marleen Kok
Keywords:
Trastuzumab
HER2 Positive Breast Cancer
Internal medicine
Monalizumab
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]